Clinitech Laboratory Financials

BSE: 544220

₹35.10

₹-1.50 (-4.10%)

As on 01-Sep-2026IST

Market cap

₹8 Cr

Revenue (TTM)

₹8 Cr

P/E Ratio

19.2

P/B Ratio

--

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	8.23	6.40	6.35	6.38	4.55	--
Total Income	8.46	6.44	6.36	6.46	4.60	--
Total Expenditure	7.40	5.40	4.98	5.32	3.73	--
EBITDA	0.83	1.00	1.36	1.07	0.83	--
Depreciation	0.45	0.44	0.45	0.38	0.25	--
EBIT	0.38	0.56	0.92	0.69	0.58	--
Interest	0.06	0.09	0.07	0.06	0.08	--
Other Income	0.23	0.04	0.02	0.07	0.04	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.55	0.51	0.86	0.70	0.55	--
Provision for Tax	0.16	0.13	0.25	0.19	0.14	--
Profit after Tax	0.39	0.37	0.61	0.51	0.40	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	8.83	3.55	2.38	1.85	1.39	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.03	0.26	1.74	0.37	0.49	--
Current Liabilities	1.68	1.63	1.76	1.36	0.77	--
Total Liabilities	10.71	5.61	6.03	3.69	2.73	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	3.21	2.73	3.91	2.20	1.01	--
Current Assets	7.34	2.71	1.96	1.38	1.63	--
Total Assets	10.71	5.61	6.03	3.69	2.73	--
Total Debt*	--	0.86	1.03	0.89	0.54	--
Net Current Assets	5.66	1.08	0.21	0.02	0.86	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-0.88	-1.28	1.25	0.96	0.38	--
Cash Flow from Investing Activities	-0.73	0.75	-0.65	-1.47	0.54	--
Cash from Financing Activities	3.98	0.45	0.09	0.29	-0.88	--
Net Cash Inflow / Outflow	2.37	-0.08	0.68	-0.22	0.04	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	1.73	2.21	4.09	3.42	2.68	--
Cash EPS (₹)	3.70	4.82	7.06	5.96	4.32	--
Adjusted Book Value (₹)	38.69	21.12	15.87	12.32	9.27	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-3.85	-7.63	8.31	6.37	5.64	--
Free Cash Flow per Share (₹)	-8.28	-15.12	7.04	-3.11	4.17	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	9.21	15.28	30.39	32.61	32.47	--
ROE (%)	6.38	12.52	29.00	31.66	28.94	--
ROA (%)	4.94	6.56	12.97	16.47	15.21	--
EBIT Margin (%)	4.64	8.77	14.46	10.77	12.81	--
Net Margin (%)	4.66	5.76	9.63	7.94	8.75	--
Cash Profit Margin (%)	10.26	12.65	16.68	13.99	14.22	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	28.61	0.87	-0.58	40.19	--	--
EBIT Growth (%)	-31.95	-38.81	33.51	17.81	--	--
Net Profit Growth (%)	6.33	-39.46	19.61	27.39	--	--
EPS Growth (%)	-21.73	-45.94	19.61	27.37	--	--
Book Value Growth (%)	148.87	49.03	28.82	32.93	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	23.27	--	--	--	--	--
Price / Book Value	1.04	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	5.77	1.78	1.27	2.00	1.01	--
Close Price (₹)	40.24	--	--	--	--	--
High Price (₹)	115.10	--	--	--	--	--
Low Price (₹)	40.05	--	--	--	--	--
Market Cap (₹ Cr)	9.18	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	--	0.24	0.43	0.48	0.39	--
Short term debt to equity ratio	--	0.16	0.28	0.25	0.00	--
Current Ratio	4.36	1.66	1.12	1.02	2.13	--
Quick Ratio	4.05	1.49	1.04	0.90	2.01	--
Interest Coverage	11.07	6.46	13.37	13.15	7.82	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	18.72	9.34	7.70	5.71	12.26	--
Asset Turnover	1.03	1.13	1.34	2.05	1.72	--
Receivable days	47.42	30.99	24.53	26.37	44.75	--
Inventory Days	18.01	12.12	8.54	7.00	7.14	--
Payable days	113.97	123.30	143.70	123.36	164.86	--
Cash Conversion Cycle	-48.54	-80.19	-110.63	-89.98	-112.97	--